On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years. It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board […]
Enhabit Inc.
The activist investor AREX Capital Management has again taken aim at Enhabit Inc. (NYSE: EHAB) in what has become an ongoing, public and back-and-forth feud. AREX Capital – which owns 4.9% of Enhabit shares, making it a top-5 shareholder – initially urged the Enhabit board to undergo a strategic review last year when the company […]
As the Centers for Medicare & Medicaid Services (CMS) cuts fee-for-service Medicare rates and Medicare Advantage (MA) penetration continues, top-tier home health companies are looking for top-tier payers to work with. Enhabit Inc. (NYSE: EHAB) considers itself a top-tier provider – regularly pointing toward its 30-day hospitalization rate, which was 20.5% below the national average […]
Enhabit Inc. (NYSE: EHAB) remains on the defensive against the activist investor AREX Capital Management. Last month, it provided more details around its completed strategic review, explaining the rationale behind remaining an independent company, in lieu of a merger or a sale. On Monday, it laid out its reasoning behind past struggles, its plan for […]
Last month, the Centers for Medicare & Medicaid Services (CMS) revealed that it planned to extend Review Choice Demonstration (RCD) for five additional years. This extension began on June 1. Though many home health providers had a bumpy start when RCD first launched, most of the industry has since adjusted. Some even view RCD as […]
Home health providers want better rates and arrangements from Medicare Advantage (MA) plans. The plans, on the other hand, sometimes still can’t figure out what they want from providers. Some of the largest home health companies have begun to make headway with MA plans. “I think the payers are recognizing that this is not a […]
When looking back at the bumpy road that has been the last couple of years, Enhabit Inc. (NYSE: EHAB) views the formation of its payer innovation team as one of its most critical moves. “Not only did we have a higher amount of fee-for-service, but the Medicare Advantage mix that we did have paid us […]
With pressure from an activist investor, Enhabit Inc. (NYSE: EHAB) has released more information surrounding its strategic review, which was completed earlier this month. Instead of a merger or sale, the Dallas-based home health and hospice company elected to remain an independent, public company. The activist investor, AREX Capital Management, previously said a sale was […]
If there were ever a time for Medicare Advantage-related troubles to cool off in the home health care space, now would be it. And, heading into the summer, some of the largest home health providers in the country are scoring demonstrable wins that could lead to future success. Virtually no one has the MA game […]
Enhabit Inc. (NYSE: EHAB) announced Wednesday the result of its strategic review. It was not a sale or a merger, but instead a commitment to the path forward as an independent public company. On Thursday, company leaders explained the rationale behind that decision, which was made unanimously by the board. Part of it is tied […]
Subscribe
Receive industry updates and breaking news from HHCN